Home › Cardiovascular Disease › Washington › Tacoma
Cardiovascular Disease clinical trials in Tacoma, WA
4 studies for Cardiovascular Disease are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Universal Research Group, LLC, Tacoma
ELEVATE-HFpEF Clinical Study
Recruiting
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- MultiCare Institute for Research and Innovation, Tacoma
- MultiCare Institute for Research and Innovation, Puyallup · 8 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Tacoma
- Research Site, Puyallup · 8 mi away
Cardiovascular Disease trials in other cities
- Boston, MA34 studies
- New York City, NY30 studies
- Washington, DC27 studies
- Dallas, TX24 studies
- Houston, TX22 studies
- Philadelphia, PA22 studies
- Pittsburgh, PA21 studies
- St. Louis, MO20 studies
- Cleveland, OH20 studies
- San Francisco, CA20 studies
- Chicago, IL20 studies
- Atlanta, GA20 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer18 studies
- Breast Cancer17 studies
- Multiple Myeloma13 studies
- Ulcerative Colitis13 studies
- Prostate Cancer11 studies
- Metastatic Cancer10 studies
- Crohn's Disease10 studies
- Colorectal Cancer10 studies
- Ovarian Cancer7 studies
- Melanoma7 studies
- Cancer (all types)6 studies
- Stomach Cancer6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.